IP vs MCRB · P/E 43, $26.62B cap vs rev $126.3M
International Paper (IP) versus Seres Therapeutics Inc (MCRB) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported MCRB revenue for 2023-12-31 was $126.3M. Net income was -$113.7M. Revenue was up 1672.2% from 2022-12-31 to 2023-12-31. MCRB currently screens at market cap $109.8M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. MCRB currently screens at market cap $109.8M.
Not investment advice. Open the IP and MCRB stock pages for the full models.
Not investment advice.